Your session is about to expire
← Back to Search
LEAP Program for Irritable Bowel Syndrome
Study Summary
This trial found that a tailored anti-inflammatory eating plan, guided by a registered dietitian, improved symptoms in people with irritable bowel syndrome.
- Irritable Bowel Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had cancer in the past and are currently receiving treatment for it.You have had kidney failure in the past.You have had a previous diagnosis of a condition called inflammatory bowel disease.You have been diagnosed with celiac disease in the past.You are currently following a different diet plan.You have moderate to severe Irritable Bowel Syndrome (IBS).
- Group 1: Participants
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the aggregate amount of people partaking in this research project?
"Yes, the information provided on clinicaltrials.gov indicates that this study is actively recruiting patients and has been doing so since it was posted 9/1/2021. Currently there are 60 open positions at one location for participants in this trial."
Does the age requirement for this medical study span beyond 65 years?
"This study seeks patients ranging from 18 to 75 years old; conversely, there are 381 trials seeking younger participants and 1009 aiming for older ones."
Is it possible to sign up for participation in this medical research?
"This clinical trial is seeking 60 volunteers with irritable bowel syndrome, who are aged 18 to 75 and satisfy the following prerequisites: a stable dose regimen for 1 month prior to enrolment, commitment to completing the study, IBS of moderate intensity or greater, and agreement to adhere to LEAP protocol for 3 months."
Are there any opportunities to join this research endeavor?
"The clinicaltrials.gov page for this trial states it is actively accepting participants, with a first posting date of September 1st 2021 and recent update on the 19th of September 2022."
Share this study with friends
Copy Link
Messenger